Jeffrey E. Russel

Array ( [id] => 1380407 [patent_doc_number] => 06559279 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-06 [patent_title] => 'Process for preparing peptide derivatized oligomeric compounds' [patent_app_type] => B1 [patent_app_number] => 09/658517 [patent_app_country] => US [patent_app_date] => 2000-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19906 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 251 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/559/06559279.pdf [firstpage_image] =>[orig_patent_app_number] => 09658517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1589232 [patent_doc_number] => 06482800 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Methods to stimulate angiogenesis' [patent_app_type] => B1 [patent_app_number] => 09/657890 [patent_app_country] => US [patent_app_date] => 2000-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9134 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 248 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482800.pdf [firstpage_image] =>[orig_patent_app_number] => 09657890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1440246 [patent_doc_number] => 06495522 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-17 [patent_title] => 'Substituted alpha-hydroxy acid caspase inhibitors and the use thereof' [patent_app_type] => B1 [patent_app_number] => 09/649810 [patent_app_country] => US [patent_app_date] => 2000-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13824 [patent_no_of_claims] => 170 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495522.pdf [firstpage_image] =>[orig_patent_app_number] => 09649810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1504066 [patent_doc_number] => 06465428 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-15 [patent_title] => 'Pharmaceutical combinations based on dalfopristine and quinupristine, and on cefepime' [patent_app_type] => B1 [patent_app_number] => 09/645563 [patent_app_country] => US [patent_app_date] => 2000-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3126 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/465/06465428.pdf [firstpage_image] =>[orig_patent_app_number] => 09645563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1337158 [patent_doc_number] => 06593292 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-15 [patent_title] => 'Compositions and methods for enhancing drug delivery across and into epithelial tissues' [patent_app_type] => B1 [patent_app_number] => 09/648400 [patent_app_country] => US [patent_app_date] => 2000-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 41 [patent_no_of_words] => 26782 [patent_no_of_claims] => 134 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593292.pdf [firstpage_image] =>[orig_patent_app_number] => 09648400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1261655 [patent_doc_number] => 06664230 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-16 [patent_title] => 'Orally administered peptides to ameliorate atherosclerosis' [patent_app_type] => B1 [patent_app_number] => 09/645454 [patent_app_country] => US [patent_app_date] => 2000-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19768 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/664/06664230.pdf [firstpage_image] =>[orig_patent_app_number] => 09645454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1204736 [patent_doc_number] => 06716452 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-06 [patent_title] => 'Active agent delivery systems and methods for protecting and administering active agents' [patent_app_type] => B1 [patent_app_number] => 09/642820 [patent_app_country] => US [patent_app_date] => 2000-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4881 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/716/06716452.pdf [firstpage_image] =>[orig_patent_app_number] => 09642820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1139603 [patent_doc_number] => 06776983 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-17 [patent_title] => 'Protein free formulations' [patent_app_type] => B1 [patent_app_number] => 09/622487 [patent_app_country] => US [patent_app_date] => 2000-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3555 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/776/06776983.pdf [firstpage_image] =>[orig_patent_app_number] => 09622487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1312986 [patent_doc_number] => 06610681 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-26 [patent_title] => 'Neurotherapeutic clavulanate composition and method' [patent_app_type] => B1 [patent_app_number] => 09/640362 [patent_app_country] => US [patent_app_date] => 2000-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 22 [patent_no_of_words] => 15616 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610681.pdf [firstpage_image] =>[orig_patent_app_number] => 09640362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420156 [patent_doc_number] => 06506730 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => 'Nasal transmucosal delivery of peptide conjugated with biocompatible polymers' [patent_app_type] => B1 [patent_app_number] => 09/639483 [patent_app_country] => US [patent_app_date] => 2000-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6089 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506730.pdf [firstpage_image] =>[orig_patent_app_number] => 09639483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4344699 [patent_doc_number] => 06290929 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Cancer treatment' [patent_app_type] => 1 [patent_app_number] => 9/627610 [patent_app_country] => US [patent_app_date] => 2000-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6997 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/290/06290929.pdf [firstpage_image] =>[orig_patent_app_number] => 627610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1470630 [patent_doc_number] => 06407212 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-18 [patent_title] => 'Method for the removal of causative agent(s) of transmissible spongiform encephalopathies from protein solutions' [patent_app_type] => B1 [patent_app_number] => 09/582644 [patent_app_country] => US [patent_app_date] => 2000-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3555 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/407/06407212.pdf [firstpage_image] =>[orig_patent_app_number] => 09582644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 558414 [patent_doc_number] => 07157429 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-01-02 [patent_title] => 'Method of regulating glucose metabolism, and reagents related thereto' [patent_app_type] => utility [patent_app_number] => 09/628225 [patent_app_country] => US [patent_app_date] => 2000-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 19031 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/157/07157429.pdf [firstpage_image] =>[orig_patent_app_number] => 09628225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1396285 [patent_doc_number] => 06541451 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-01 [patent_title] => 'Streptogramin derivatives, their preparation and compositions containing them' [patent_app_type] => B1 [patent_app_number] => 09/627791 [patent_app_country] => US [patent_app_date] => 2000-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39388 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 870 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541451.pdf [firstpage_image] =>[orig_patent_app_number] => 09627791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342416 [patent_doc_number] => 06586403 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-01 [patent_title] => 'Treating allergic reactions and inflammatory responses with tri-and dipeptides' [patent_app_type] => B1 [patent_app_number] => 09/620249 [patent_app_country] => US [patent_app_date] => 2000-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 13 [patent_no_of_words] => 11809 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586403.pdf [firstpage_image] =>[orig_patent_app_number] => 09620249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1387910 [patent_doc_number] => 06541023 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-01 [patent_title] => 'Use of collagen of aquatic origin for the production of supports for tissue engineering, and supports and biomaterials obtained' [patent_app_type] => B1 [patent_app_number] => 09/616282 [patent_app_country] => US [patent_app_date] => 2000-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 6533 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541023.pdf [firstpage_image] =>[orig_patent_app_number] => 09616282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1368807 [patent_doc_number] => 06566327 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'Histogranin peptides and their analgesic use' [patent_app_type] => B1 [patent_app_number] => 09/530123 [patent_app_country] => US [patent_app_date] => 2000-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 8027 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566327.pdf [firstpage_image] =>[orig_patent_app_number] => 09530123 [rel_patent_id] =>[rel_patent_doc_number] =>)